<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.moneycontrol.com/news/business/stocks/glenmark-pharma-share-price-gains-on-final-approval-from-usfda-4625671.html?utm_source=dlvr.it&amp;utm_medium=facebook"/>
    <meta property="og:site_name" content="Moneycontrol"/>
    <meta property="article:published_time" content="2019-11-11T00:00:00+00:00"/>
    <meta property="og:title" content="Glenmark Pharma share price gains on final approval from USFDA"/>
    <meta property="og:description" content="The company's current portfolio consists of 163 products authorized for distribution in the US marketplace and 45 ANDA’s pending approval with the US FDA."/>
  </head>
  <body>
    <article>
      <h1>Glenmark Pharma share price gains on final approval from USFDA</h1>
      <h2>The company's current portfolio consists of 163 products authorized for distribution in the US marketplace and 45 ANDA’s pending approval with the US FDA.</h2>
      <address>
        <time datetime="2019-11-11T00:00:00+00:00">11 Nov 2019</time>
      </address>
      <p>Shares of <a href="http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/glenmarkpharma/GP08">Glenmark Pharma</a> added more than 1 percent intraday on November 11 after the company received final approval from the United States Food &amp; Drug Administration (USFDA).</p>
      <p>Glenmark Pharmaceuticals Inc., USA has been granted final approval by the USFDA for Adapalene and Benzoyl Peroxide Gel, 0.1%|2.5%, the generic version of Epiduo1 Gel, 0.1%|2.5%, of Galderma Laboratories L.P.</p>
      <p>The Epiduo Gel market achieved annual sales of approximately $33.7 million, as per IQVIATM sales data for the 12 month period ending September 2019.</p>
      <p>
        <a href="https://www.moneycontrol.com/news/business/stocks/javascript:;">Close</a>
      </p>
      <p>The company's current portfolio consists of 163 products authorised for distribution in the US marketplace and 45 ANDA’s pending approval with the US FDA.</p>
      <p>In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio, the company said press release.</p>
      <p>At 1038 hrs, Glenmark Pharma was quoting at Rs 290.90, up Rs 4.30, or 1.50 percent on the BSE.<a href="https://www.moneycontrol.com/promos/pro.php">Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights &amp; analysis For more information, check out the Moneycontrol website or mobile app.</a></p>
    </article>
  </body>
</html>